PepGen annual current ratio
2021
2022
2023
2024
2025
PepGen Current Ratio Growth & History (PEPG)
PepGen's current ratio was 11.94 for fiscal 2025.
View full PepGen company overviewPepGen annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 11.94 | 4.52 | +61.04% |
| 2024 | 2024-12-31 | 7.41 | 0.99 | +15.33% |
| 2023 | 2023-12-31 | 6.43 | −3.46 | −34.97% |
| 2022 | 2022-12-31 | 9.88 | −3.68 | −27.13% |
| 2021 | 2021-12-31 | 13.56 | — | — |
PepGen quarterly current ratio
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 13.36 | 8.63 | +182.13% |
| Q1 2026 | 2026-03-31 | 14.98 | 10.03 | +202.86% |
| Q4 2025 | 2025-12-31 | 11.94 | 4.52 | +61.04% |
| Q3 2025 | 2025-09-30 | 13.15 | 4.68 | +55.23% |
| Q2 2025 | 2025-06-30 | 4.74 | −2.72 | −36.46% |
| Q1 2025 | 2025-03-31 | 4.95 | −10.83 | −68.65% |
| Q4 2024 | 2024-12-31 | 7.41 | 0.99 | +15.33% |
| Q3 2024 | 2024-09-30 | 8.47 | 2.12 | +33.35% |
| Q2 2024 | 2024-06-30 | 7.45 | −1.43 | −16.05% |
| Q1 2024 | 2024-03-31 | 15.78 | 6.43 | +68.82% |
| Q4 2023 | 2023-12-31 | 6.43 | −3.46 | −34.97% |
| Q3 2023 | 2023-09-30 | 6.35 | −6.81 | −51.74% |
| Q2 2023 | 2023-06-30 | 8.88 | −2.13 | −19.33% |
| Q1 2023 | 2023-03-31 | 9.35 | 1.55 | +19.89% |
| Q4 2022 | 2022-12-31 | 9.88 | −3.68 | −27.13% |
| Q3 2022 | 2022-09-30 | 13.16 | — | — |
| Q2 2022 | 2022-06-30 | 11.01 | — | — |
| Q1 2022 | 2022-03-31 | 7.79 | — | — |
| Q4 2021 | 2021-12-31 | 13.56 | — | — |
PepGen current ratio trends
Between the periods ended 2021-12-31 and 2025-12-31, PepGen's current ratio decreased from 13.56 to 11.94, a change of −1.63. The latest reported quarter, Q2 2026, shows 13.36.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review PepGen source filings ↗Community posts
Novartis’ DM1 trial misses its primary endpoint
Novartis’ ($NVS) del-desiran failed to show a statistically significant improvement on the primary endpoint in the Phase III HARBOR trial for myotonic dystrophy type 1. The company will continue analysing the data and discuss next steps wit ...